Lavo Life Sciences Analysis: $0.5M Raised
What is Lavo Life Sciences?
Lavo Life Sciences specializes in AI-accelerated crystal structure prediction for small molecule drugs. Their unique approach combines AI and computational chemistry to enhance drug development processes. This technology enables faster identification of crystal forms, reducing risks and development timelines for pharmaceutical companies.
HQ Country
San Francisco, United States
Employees
1-10
Founded
2022
Industry
AI/ML, HealthTech, Pharmaceuticals
Product Features & Capabilities
- AI-powered crystal structure prediction platform
- Web-based Crystal Console for crystallography analysis
- Virtual polymorph screening to identify risks
- PXRD analysis for comparing data
- Comprehensive crystal structure analysis tools.
How much Lavo Life Sciences raised
1 - $500,000
April 5, 2023Lead Investor: Y Combinator, Eastlink Capital
